World's most valuable pharmaceutical brands 2019 by brand value

Swiss multinational company Roche maintained its position as the world’s most valuable pharmaceutical brand in 2019. The company’s brand value was estimated at 6.91 billion U.S. dollars, an increase of around 500 million U.S. dollars on the previous year.

Competition from generics is a cause for concern

Roche continues to face competition from Bayer in the battle to become the most valuable pharmaceutical brand – the gap between the two drug giants narrowed to around 700 million U.S. dollars in 2019. Sales growth in the United States ensured that Roche stayed ahead of its rivals, but falling revenues in Europe remain a cause for concern. Worldwide sales of its branded drug Herceptin decreased between 2018 and 2019, with sales in Europe falling by more than 800 million Swiss francs due to generic versions of the drug entering the market.

Growth through mergers and acquisitions

Roche has increased its research and development expenditure each year since 2011. Creating groundbreaking treatments is one way of maintaining the company’s status as the most valuable pharmaceutical brand, but another method is to increase market share through mergers and acquisitions. Companies are increasingly using this strategy as a way of limiting the impact of falling revenues caused when cheaper generics are made available to consumers. Roche’s acquisition of Foundation Medicine in 2018 was an indication of the company’s plans to gain a competitive advantage.

Brand value of the world's most valuable pharmaceutical brands as of 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until September 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date




Survey time period

as of 2019

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pfizer"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.